Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab

OBJECTIVES: This study aimed to explore the effects of vascular endothelial growth factor A (VEGFA) gene polymorphisms (rs699947 and rs833061) on Bevacizumab (BEV) treatment in colorectal cancer (CRC) patients. METHODS: 125 CRC cases receiving BEV plus FOLFIRI treatment were recruited in this study....

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Wei, Li, Feng, Yuan, Qiang, Chen, Gang, Chen, Cailing, Yu, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739652/
https://www.ncbi.nlm.nih.gov/pubmed/29285265
http://dx.doi.org/10.18632/oncotarget.22295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5739652/
https://www.ncbi.nlm.nih.gov/pubmed/29285265
http://dx.doi.org/10.18632/oncotarget.22295

Ejemplares similares